Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	52.78B +14.3%
Revenue (ttm)	18.30B -18.7%
Net Income	1.67B -43.8%
EPS	1.04 -45.0%
Shares Out	1.59B
PE Ratio	31.85
Forward PE	28.67
Dividend	0.63 (1.90%)
Ex-Dividend Date	Oct 21, 2025

Volume	10,097,300
Average Volume	13,900,288
Open	33.33
Previous Close	33.18
Day's Range	32.10 - 33.54
52-Week Range	28.14 - 41.72
Beta	-0.01
RSI	53.03
Earnings Date	Apr 3, 2026

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. It operates through Twinings, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-em...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 21,864
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.